Introduction {#sec1}
============

Systemic sclerosis (SSc) is an autoimmune connective tissue disorder that affects various body parts, particularly skin, digestive tract, lungs and heart \[[@cit0001], [@cit0002]\]. Digestive complications such as esophagus sequelae are common in SSc and nearly 90% of patients with SSc show at least one upper GI symptom \[[@cit0003]\]. Anorectal infringement is also frequent in SSc patients (50--70%), often resulting in bowel incontinence and additional anorectal disorders \[[@cit0004]\]. Anorectal involvement might typically cause fecal incontinence and rarely rectal prolapse. If a prolapse occurs it is a substantial problem, especially in elderly patients. In these cases, prolapse is the leading problem in the so-called prolapse syndrome, which is a combination of prolapse as well as constipation and fecal incontinence \[[@cit0005]\]. The increased viscosity of secretion and associated constipation might be the underlying condition leading to heavy straining \[[@cit0006]\]. The majority of patients facing rectal prolapse are aged eighty years and older \[[@cit0007]\].

In order to present the variety and harmful character of rectal prolapse in combination with SSc, three cases are provided in this series.

Case reports {#sec2}
============

Patient 1 {#sec2.1}
---------

A 65 year-old woman presented in March 2014 with a third degree rectal prolapse and third degree incontinence. She was suffering from a limited form of cutaneous SSc since 2009 with symptoms of Raynaud's syndrome, acral erosions and puffy fingers. No esophagus or other GI tract involvement was observed, antibody profile was ANA HEP2 positive and CENP-B positive. At the time of initial treatment of rectal prolapse, medication with methotrexate was given.

In March 2014 she underwent laparoscopic anterior rectal resection and rectopexy with resection of 55 cm of sigmoid colon.

In September 2014 the patient reported a prolapse recurrence, the clinical examination showed an isolated ventral recurrence ([Fig. 1](#f0001){ref-type="fig"}). She underwent transanal rectal full wall resection using Altemeier technique. The resection weight was 14 g only.

![Prolapsing ventral rectal wall in SSc patient.](RU-55-29892-g001){#f0001}

In April 2015 the patient received sacral nerve stimulation for third degree incontinence. Prior to this, testing for sacral nerve modulation was positive and fecal incontinence improved.

In May 2015 a second rectal prolapse reoccurred. At this time the patient underwent an extracorporeal rectal resection, so called Altemeier procedure again. In contrast to the procedure in 2014, this time a circular resection was necessary.

At the last follow-up in June 2016, there was no evidence of prolapse recurrence, but third degree incontinence with urge symptoms remained.

Patient 2 {#sec2.2}
---------

An 82 year-old woman was diagnosed for ventral third degree rectal prolapse and third degree incontinence in May 2014. SSc was diagnosed in 2009 as diffuse systemic cutaneous form with a modified Rodnan skin score of 15/51 (2012) and a Raynaud's syndrome. In addition, motility problems of the esophagus and distended stomach as evidence of delay gastric emptying, in the absence of a mechanical obstruction, were diagnosed. Since 2009, patient received methotrexate treatment. Antibody status at the first time of surgery was ANA positive, SCL-70 positive.

The patient underwent extra corporal rectal resection of the ventral aspect of the rectum in so-called Transtar technique. The specimen weight was 16 g.

In November 2015 the patient was readmitted with a circumferential recurrence. At this time she underwent extra corporal rectal resection in Altemeier technique.

The last follow-up examination showed no evidence of prolapsed recurrence, but third degree incontinence persists.

Patient 3 {#sec2.3}
---------

A 72 year-old woman, first admission in 2012, with rectal mucosa prolapses associated with an obstructed defecation and a cystocele ([Figs. 2](#f0002){ref-type="fig"}--[4](#f0004){ref-type="fig"}) in combination with third degree incontinence. The prolapse was treated by a transanal rectal resection (STARR) of 6 cm rectal height. At that time she was suffering limited systemic cutaneous sclerosis, first diagnosed in 1992, with dermatosclerosis, cutaneous calcinosis, Raynaud syndrome, modified Rodnan Skin score was 24/51 (2012). The patient was also suffering from gastro-esophageal reflux disease (GERD), first degree Barrett esophagus, hiatal hernia and gastric dysmotility. According to the antibody status, only ANA with centromere fluorescence pattern was positive. Also this patient suffered from arterial pulmonary hypertension (Dana Point Classification Stage 1) and since 2009 the patient have been received dual endothelin receptor antagonist -- bosentan in dose 125 mg.

![MRI Defecography: sagittal section of the pelvis in SSc patient: large distension of the bladder and distended rectum.](RU-55-29892-g002){#f0002}

![MRI Defecography: sagittal section of the pelvis in SSc patient: at beginning of defecation.](RU-55-29892-g003){#f0003}

![MRI Defecography: sagittal section of the pelvis in SSc patient: at the end of defecation the pelvis is lowered and a wide rectocele is shown.](RU-55-29892-g004){#f0004}

In April 2014 a ventral recurrences was diagnosed and the patient underwent partial extra-corporal full thickness rectal resection in Altemeier technique.

In March 2015 the patient faced a second recurrence and at this time a circular Altemeier procedure was necessary. However, at this time only a limited resection was possible, due to the fixation of the dorsal aspect of the rectal wall.

Finally in May 2016, again a third degree rectal prolapse was visible. The patient underwent a third Altemeier procedure. This time 27 cm of sigmoid colon was resected and transanal anastomosis was sutured.

The last follow-up examination showed no evidence of prolapsed recurrence, but persisting third degree incontinence.

Discussion {#sec3}
==========

Here we presented three cases of SSc patients with third degree rectal prolapse focusing on the specific dilemma of anorectal function in SSc.

Overall GI affection is seen in about 90% of patients with SSc \[[@cit0003], [@cit0006]\]. Anorectal involvement was reported in 50% to 70% of SSc patients \[[@cit0008]\]. Anorectal dysfunction might be closely linked to esophageal involvement in SSc \[[@cit0009]\]. A typical expression of SSc in the lower GI tract is a combination of constipation, fecal incontinence and rectal prolapse \[[@cit0006], [@cit0010]\], which is also known as rectal prolapse syndrome in patients with non-SSc rectal prolapse.

In general, pathophysiology of rectal prolapse and concomitant incontinence is closely related to disordered collagen synthesis and dystrophic muscle and damage during childbirth. In SSc, the pathophysiology of fecal incontinence is most likely related to neuropathy as suggested by absent rectal inhibition reflex and higher anal sensory threshold and is related less so to sphincter atrophy and rectal fibrosis in contrast to gut dismotility \[[@cit0009], [@cit0011]\]. The choline-associated motility-mechanism is disturbed. A participation of the colon is important as already mentioned with constipation, frequently associated with fecal incontinence.

Thoua et al. \[[@cit0012]\] reported that patients with SSc have a thin and atrophic internal anal sphincter, which suggests that internal sphincter atrophy develops even in asymptomatic patients and this may be amenable to treatment with sacral neuromodulation.

Lower voluntary squeeze pressure in incontinent SSc patients and external anal sphincter (EAS) sonographic abnormalities only in SSc patients with incontinence suggest that the EAS is of major importance for fecal continence in SSc patients. The finding of an increased fiber density further supports involvement of EAS in SSc and could indicate previous nerve injury with consequent incomplete re-innervation. SSc patients with incontinence also have a thin internal anal sphincter and a low resting pressure. Centromeric antibodies and in particular vascular disease have been identified as possible risk factors for anal incontinence among SSc patients \[[@cit0013]\]. It is unclear whether ischemic events are responsible for the nerve damage or not \[[@cit0014]\].

In conclusion, both nerval and vascular factors are involved in GI involvement in SSc. Nevertheless, SSc patients show impaired anorectal pressures, sensations, and rectal compliance \[[@cit0015]\].

In addition to the findings on the mechanisms of incontinence and constipation, the data presented here potentially might suggest clinical pattern of rectal prolapse in SSc, with the following clinical implication.

In patients with SSc, rectal prolapse syndrome possibly might occur at an earlier age compared to patients with non-SSc prolapse. Various publications showed a mean age of patients with third degree rectal prolapse at the age of 80 years and above \[[@cit0005], [@cit0007]\].

A primary prolapse of the ventral aspect of the rectal wall was the first symptom of SSc related prolapse in this group. This aspect was not reported so far. The question arises whether this ventral prolapse is due to excessive straining, caused by high viscosity of stool in SSc patients.

In our SSc patients, the recurrence rate after surgery is high. In contrast to other non-SSc rectal prolapse patients, where recurrence rate after surgery, independent to the surgical technique for prolapse repair, should be significant lower. E.g. for transanal resections a recurrence rate of 10% is a reasonable recurrence rate \[[@cit0007], [@cit0016]--[@cit0018]\]. The question of surgical access to rectal prolapse in patients with SSc does most likely not differ from other patients with non-SSc rectal prolapse. A Cochrane-analysis was unable to identify or refute clinically important differences between the alternative surgical operations \[[@cit0019]\]. Thus, transabdominal as well as transanal access for surgical repair are reasonable in SSc patients \[[@cit0004]\].
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